Related Experiment Video

Updated: Feb 28, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

773

A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Nicholas J Short1, Hagop Kantarjian2, Elias Jabbour2

  • 1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

British Journal of Haematology
|June 16, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD22acute lymphoblastic leukaemiaimmunotoxinmoxetumomab pasudotoxrelapsed/refractory

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.9K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

862

Related Concept Videos